AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.1436
-0.0050 (-3.36%)
At close: Nov 13, 2026, 4:00 PM EST
0.1536
+0.0100 (6.96%)
After-hours: Nov 13, 2026, 6:56 PM EST
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $4.37 million as of November 13, 2026. It is the 45,207th most valuable company in the world and the 5,985th biggest in the United States. Its market cap has increased by 0.09% in one year.
Market Cap
4.37M
Enterprise Value
-905.51K
1-Year Change
0.09%
Global Rank
Country Rank
#5,985 United States
Category
ChartMarket Cap Chart
Since July 12, 1996, AIM ImmunoTech's market cap has decreased from $40.85M to $4.37M, a decrease of -89.30%. That is a compound annual growth rate of -7.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 4.37M | 35.59% |
| Dec 31, 2025 | 3.22M | -74.47% |
| Dec 31, 2024 | 12.63M | -41.22% |
| Dec 29, 2023 | 21.49M | 43.27% |
| Dec 30, 2022 | 15.00M | -65.93% |
| Dec 31, 2021 | 44.02M | -39.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 4.99M |
| Senti Biosciences Holdings | 4.90M |
| Pulmatrix | 4.78M |
| Niki BioSolutions | 4.61M |
| Xenetic Biosciences | 4.37M |
| PharmaCyte Biotech | 4.28M |
| Creative Medical Technology Holdings | 4.15M |
| Alaunos Therapeutics | 4.09M |